Profiles: News
News
- +
Dung beetles and the sneaky f…er strategy 01/09/2008 14:08:00
Beetles and crickets offer the perfect model for studying sexual selection and the primacy of female choice.Beetles and crickets offer the perfect model for studying sexual selection and the primacy of female choice. - +
The turn of the worm 29/08/2008 13:57:00
The cotton bollworm, the world's most economically destructive insect pest, is having its genome sequenced.The cotton bollworm, the world's most economically destructive insect pest, is having its genome sequenced. - +
Excess iron and Friedreich’s ataxia 28/08/2008 13:40:00
While Friedreich’s ataxia is a rare disorder, tracking down the role of the protein implicated in the disease has opened up new therapeutic potentials.While Friedreich’s ataxia is a rare disorder, tracking down the role of the protein implicated in the disease has opened up new therapeutic potentials. - +
The motherfish and the stunned mullet 27/08/2008 13:31:00
The recent announcement of “the oldest mother ever discovered” made headlines around the world for Dr John Long and his colleagues, but Materpiscis Attenboroughi is just one of numerous finds Long has made at the Gogo Formation in WA over the last two decades.The recent announcement of “the oldest mother ever discovered” made headlines around the world for Dr John Long and his colleagues, but Materpiscis Attenboroughi is just one of numerous finds Long has made at the Gogo Formation in WA over the last two decades. - +
A bank designed to profit all 26/08/2008 13:18:00
A pocket of middle Australia on the northern outskirts of Perth is the setting for a proposed biobanking project that even its instigator, Professor Lyle Palmer of the University of Western Australia, calls “ludicrously ambitious”.A pocket of middle Australia on the northern outskirts of Perth is the setting for a proposed biobanking project that even its instigator, Professor Lyle Palmer of the University of Western Australia, calls “ludicrously ambitious”. - +
Genera launches with PapTest 25/08/2008 13:11:00
Genera Biosystems is distributing its new HPV test through Gribbles Pathology and promises more in the booming molecular diagnostics field.Genera Biosystems is distributing its new HPV test through Gribbles Pathology and promises more in the booming molecular diagnostics field. - +
Mover and shaker of the genome 19/08/2008 13:17:00
Epigenetics is moving from the laboratory to the clinic and the pharmacy, with several histone deacetylase inhibitors on the market and epigenetic screening likely to become as widespread as genetic screening.Epigenetics is moving from the laboratory to the clinic and the pharmacy, with several histone deacetylase inhibitors on the market and epigenetic screening likely to become as widespread as genetic screening. - +
Microbiologist to the stars 18/08/2008 12:50:00
Malcolm Walter has moved his collection of rocks from Macquarie University to the University of NSW, where he has joined Brett Neilan and his colleagues in an expanded multidisciplinary team as part of the new Australian Centre for Astrobiology (ACA).Malcolm Walter has moved his collection of rocks from Macquarie University to the University of NSW, where he has joined Brett Neilan and his colleagues in an expanded multidisciplinary team as part of the new Australian Centre for Astrobiology (ACA). - +
Colman wins Victoria Prize 13/08/2008 15:07:00
WEHI’s Peter Colman wins Victoria’s top science prizeWEHI's Peter Colman wins Victoria's top science prize - +
Pharma and academia - how opposites attract 07/08/2008 11:49:09
They may have sneered at each other in the past, but collaborative efforts for translational research between academia and industry are happening, and they are working.They may have sneered at each other in the past, but collaborative efforts for translational research between academia and industry are happening, and they are working. - +
Patent on the destination 07/08/2008 11:46:14
Australian medical device company Ventracor is so pleased with its clinical trial design, it’s decided to apply for a patent for it.Australian medical device company Ventracor is so pleased with its clinical trial design, it's decided to apply for a patent for it.
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
Beyond The Hybrid TV Card Norm 2008-08-26 15:29:00+10
Go Green with Kingston - Save the PCB, Save the World 2008-08-25 16:10:00+10
VIA Pico-ITX at the Heart of Modern Robots 2008-08-25 13:50:00+10
Fujitsu unveils winning formula for success with Intel® Centrino® 2 processor technology. 2008-08-25 12:42:00+10
Multimedia Technology & Herma Technologies announce new audience feedback solution from REPLY Systems. 2008-08-19 11:05:00+10
Sponsored Links


